These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2702147)

  • 21. Chronic and intradialytic effects of high-flux hemodialysis on tumor necrosis factor-alpha production: relationship to endotoxins.
    Mege JL; Sanguedolce MV; Purgus R; Moulin B; Bongrand P; Capo C; Olmer M
    Am J Kidney Dis; 1992 Nov; 20(5):482-8. PubMed ID: 1279968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dialysis membranes on the kinetics of tumor necrosis factor-alpha production by peripheral mononuclear cells in chronic hemodialysis patients.
    Kushihata S; Yorioka N; Oda H; Ye XF; Yamakido M
    Int J Artif Organs; 1998 Jul; 21(7):384-90. PubMed ID: 9745992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fate of beta-2-microglobulin during dialysis on polysulfone and AN69 membranes.
    Goldman M; Nortier J; Dhaene M; Amraoui Z; Vanherweghem JL
    Contrib Nephrol; 1989; 74():127-31. PubMed ID: 2702129
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of cuprophan, hemophan and polysulfone membranes on the oxidative metabolism, degranulation reaction, enzyme release and pulmonary sequestration of granulocytes.
    Kolb G; Fischer W; Schoenemann H; Bathke K; Höffken H; Müller T; Lange H; Joseph K; Havemann K
    Contrib Nephrol; 1989; 74():10-21. PubMed ID: 2562018
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of endotoxin-contaminated dialysate and polysulfone or cellulosic membranes on the release of TNF alpha during simulated dialysis.
    Arduino MJ; Bland LA; McAllister SK; Favero MS
    Artif Organs; 1995 Sep; 19(9):880-6. PubMed ID: 8687293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of interleukin-1 during hemodialysis.
    Haeffner-Cavaillon N; Jahns G; Poignet JL; Kazatchkine MD
    Kidney Int Suppl; 1993 Jan; 39():S139-43. PubMed ID: 8468916
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
    Lonnemann G; Koch KM; Shaldon S; Dinarello CA
    J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
    Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipid metabolism in hemofiltration. Comparison with the lipid pattern of hemodialyzed patients].
    Civati G; Galato R; Franceschini G; Guastoni C; Perego A; Minetti L
    Minerva Nefrol; 1980; 27(4):669-74. PubMed ID: 7254694
    [No Abstract]   [Full Text] [Related]  

  • 31. Biocompatible membranes in acute renal failure.
    Shaldon S
    Lancet; 1996 Jan; 347(8995):205-6. PubMed ID: 8544586
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of bradykinin in anaphylactoid reactions during hemodialysis with AN69 dialyzers.
    Schaefer RM; Fink E; Schaefer L; Barkhausen R; Kulzer P; Heidland A
    Am J Nephrol; 1993; 13(6):473-7. PubMed ID: 8141183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of first use and reuse of cuprophan membranes on interleukin-1 receptor antagonist and interleukin-1 beta production by blood mononuclear cells.
    Pereira BJ; King AJ; Poutsiaka DD; Strom JA; Dinarello CA
    Am J Kidney Dis; 1993 Aug; 22(2):288-95. PubMed ID: 8352255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes.
    Bouman CS; van Olden RW; Stoutenbeek CP
    Blood Purif; 1998; 16(5):261-8. PubMed ID: 9917534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypersensitivity reactions to synthetic haemodialysis membranes — an emerging issue?
    Alvarez-de Lara MA; Martín-Malo A
    Nefrologia; 2014 Nov; 34(6):698-702. PubMed ID: 25415569
    [No Abstract]   [Full Text] [Related]  

  • 36. Challenge of phagocyte metabolism by extracorporeal circulation and membrane contact. A biocompatibility test.
    Vanholder RC; Dhondt A; Ringoir SM
    ASAIO Trans; 1988; 34(3):543-5. PubMed ID: 3143383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of beta 2-microglobulin by adsorption on dialysis membranes.
    Goldman M; Dhaene M; Vanherweghem JL
    Nephrol Dial Transplant; 1987; 2(6):576-7. PubMed ID: 3126461
    [No Abstract]   [Full Text] [Related]  

  • 38. [High-performance membranes].
    Suzuki M; Endoh N; Nakagawa I; Nakamura F
    Nihon Rinsho; 1991 Dec; 49 Suppl():141-8. PubMed ID: 1808246
    [No Abstract]   [Full Text] [Related]  

  • 39. Eicosanoid release as an indicator of membrane biocompatibility.
    Schultze G; Wagner K; Neumayer HH; Molzahn M
    Contrib Nephrol; 1987; 59():44-50. PubMed ID: 3442987
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocyte DNA synthesis and surface antigen expression in chronic dialysis: comparative effects of cuprophan and polysulfone membranes.
    Stefoni S; Nanni Costa A; Colì L; Bonomini M; Buscaroli A; Raimondi C; Stagni B; Cianciolo G; Bonomini V
    Contrib Nephrol; 1989; 74():66-70. PubMed ID: 2702148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.